Literature DB >> 3021850

The effects of adenosine agonists on human neutrophil function.

D J Schrier, K M Imre.   

Abstract

Adenosine is a potent physiologic substance with a variety of biologic activities. Many of the effects of adenosine appear to be mediated by two populations of cell-surface adenosine receptors (A1 and A2). We have examined the effects of several adenosine receptor agonists on human neutrophils stimulated with the chemotactic peptide N-formyl-methionyl-leucyl-phenylalanine (FMLP). The results indicate that both superoxide anion generation and degranulation (as assessed by lysozyme release) are inhibited. Inhibition correlated most strongly with A2 receptor affinity for both parameters and was reversible by the adenosine receptor antagonist 8-phenyltheophylline. Because toxic oxygen metabolites and degradative enzymes are implicated in a variety of inflammatory disorders, adenosine agonists may be useful probes to help expand our knowledge of the role of these mediators in human disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021850

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  A(2A) adenosine receptors in human peripheral blood cells.

Authors:  S Gessi; K Varani; S Merighi; E Ongini; P A Borea
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

Review 2.  Regulation of neutrophil function by adenosine.

Authors:  Kathryn E Barletta; Klaus Ley; Borna Mehrad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04       Impact factor: 8.311

3.  Effects of adenosine on guinea pig pulmonary eosinophils.

Authors:  B A Walker
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

Review 4.  The role of neutrophils in vascular injury: a summary of signal transduction mechanisms in cell/cell interactions.

Authors:  G Weissmann
Journal:  Springer Semin Immunopathol       Date:  1989

5.  Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells.

Authors:  B N Cronstein; M A Eberle; H E Gruber; R I Levin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

6.  Characterization of a phosphomonoesterase from Brucella abortus.

Authors:  A K Saha; N K Mukhopadhyay; J N Dowling; T A Ficht; L G Adams; R H Glew
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

7.  The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively.

Authors:  B N Cronstein; L Daguma; D Nichols; A J Hutchison; M Williams
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

8.  Adenosine and 2-phenylaminoadenosine (CV-1808) inhibit human neutrophil bactericidal function.

Authors:  G E Hardart; G W Sullivan; H T Carper; G L Mandell
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

9.  Nonsteroidal antiinflammatory agents inhibit stimulated neutrophil adhesion to endothelium: adenosine dependent and independent mechanisms.

Authors:  B N Cronstein; M Van de Stouwe; L Druska; R I Levin; G Weissmann
Journal:  Inflammation       Date:  1994-06       Impact factor: 4.092

10.  Purine catabolism in polymorphonuclear neutrophils. Phorbol myristate acetate-induced accumulation of adenosine owing to inactivation of extracellularly released adenosine deaminase.

Authors:  G van Waeg; G Van den Berghe
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.